相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas
Madhumeeta Chadha et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2022)
Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma
Basudeb Das et al.
GENE (2022)
Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
Benjamin A. Nacev et al.
NATURE COMMUNICATIONS (2022)
Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets
Zijian Zou et al.
FRONTIERS IN ONCOLOGY (2022)
Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis
Jing Han et al.
CANCER LETTERS (2021)
The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies
Daqian Xu et al.
CELL METABOLISM (2021)
Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses
Biyu Zhang et al.
GENE (2021)
Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma
Xiaoshuai Wang et al.
LIFE SCIENCES (2021)
Time-resolved non-invasive metabolomic monitoring of a single cancer spheroid by microfluidic NMR
Bishnubrata Patra et al.
SCIENTIFIC REPORTS (2021)
Development and validation of prognostic markers in sarcomas base on a multi-omics analysis
Yongchun Song et al.
BMC MEDICAL GENOMICS (2021)
Metabolomics in cancer research and emerging applications in clinical oncology
Daniel R. Schmidt et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
Jingjing Han et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
In Vitro Spatio-Temporal NMR Metabolomics of Living 3D Cell Models
Robert Knitsch et al.
ANALYTICAL CHEMISTRY (2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Gronchi et al.
ANNALS OF ONCOLOGY (2021)
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
S. J. Strauss et al.
ANNALS OF ONCOLOGY (2021)
Metabolic landscapes in sarcomas
Richard Miallot et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nathaniel D. Anderson et al.
NATURE COMMUNICATIONS (2021)
Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness
Yongjin Yoo et al.
CANCERS (2021)
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma
Boran Pang et al.
FRONTIERS IN ONCOLOGY (2021)
Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis
Peiwei Huangyang et al.
CELL METABOLISM (2020)
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor
Kathryn M. Lemberg et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Deep sequencing of myxoinflammatory fibroblastic sarcoma
Elsa Arbajian et al.
GENES CHROMOSOMES & CANCER (2020)
Targeting glutamine metabolism slows soft tissue sarcoma growth
Pearl Lee et al.
NATURE COMMUNICATIONS (2020)
IDO Targeting in Sarcoma: Biological and Clinical Implications
Imane Nafia et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
Shogo Kumagai et al.
IMMUNITY (2020)
Towards applying NMR relaxometry as a diagnostic tool for bone and soft tissue sarcomas: a pilot study
Elzbieta Masiewicz et al.
SCIENTIFIC REPORTS (2020)
Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma
Wenshuai Liu et al.
BMC CANCER (2020)
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
Martin F. Orth et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Requirement for YAP1 signaling in myxoid liposarcoma
Marcel Trautmann et al.
EMBO MOLECULAR MEDICINE (2019)
Identification of bioactive metabolites using activity metabolomics
Markus M. Rinschen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomas
Tom Lesluyes et al.
MODERN PATHOLOGY (2019)
Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone
Naser M. Ali et al.
JOURNAL OF PATHOLOGY (2019)
KRAS4A directly regulates hexokinase 1
Caroline R. Amendola et al.
NATURE (2019)
Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma
Chang-Lung Lee et al.
JCI INSIGHT (2019)
NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction
Edoardo Gaude et al.
MOLECULAR CELL (2018)
A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates
Kelly A. Mercier et al.
SCIENTIFIC REPORTS (2018)
Four Key Steps Control Glycolytic Flux in Mammalian Cells
Lukas Bahati Tanner et al.
CELL SYSTEMS (2018)
Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas A Phase 2 Clinical Trial
Maud Toulmonde et al.
JAMA ONCOLOGY (2018)
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Priya Londhe et al.
FRONTIERS IN ONCOLOGY (2018)
Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
Victoire Gouirand et al.
FRONTIERS IN ONCOLOGY (2018)
Interplay between YAP/TAZ and Metabolism
Ja Hyun Koo et al.
CELL METABOLISM (2018)
Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma
Abdalla D. Mohamed et al.
SCIENTIFIC REPORTS (2018)
Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer
Marcus D. Goncalves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Soft Tissue Sarcoma Cancer Stem Cells: An Overview
Katia C. Genadry et al.
FRONTIERS IN ONCOLOGY (2018)
Genomic profiling of dedifferentiated liposarcoma compared to matched well-differentiated liposarcoma reveals higher genomic complexity and a common origin
Hannah C. Beird et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2018)
Prognostic Metabolite Biomarkers for Soft Tissue Sarcomas Discovered by Mass Spectrometry Imaging
Sha Lou et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2017)
Evolving biological understanding and treatment of sarcomas
Jean-Yves Blay et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Arginine Deprivation Inhibits the Warburg Effect and Upregulates Glutamine Anaplerosis and Serine Biosynthesis in ASS1-Deficient Cancers
Jeff Charles Kremer et al.
CELL REPORTS (2017)
Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas
Alexander J. Lazar et al.
CELL (2017)
Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?
Giuseppina Sannino et al.
CANCER RESEARCH (2017)
Application of metabolomics in sarcoma: From biomarkers to therapeutic targets
Li Min et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Multinuclear NMR and MRI Reveal an Early Metabolic Response to mTOR Inhibition in Sarcoma
Valentina Di Gialleonardo et al.
CANCER RESEARCH (2017)
The genomic landscape of epithelioid sarcoma cell lines and tumours
Farzad Jamshidi et al.
JOURNAL OF PATHOLOGY (2016)
Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma
Lulu Mao et al.
JOURNAL OF PINEAL RESEARCH (2016)
Metabolic adaptation of tissues to stress releases metabolites influencing innate immunity
Philippe Naquet et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Tumor-associated fibroblasts promote the proliferation and decrease the doxorubicin sensitivity of liposarcoma cells
Kamran Harati et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
Edoardo Gaude et al.
NATURE COMMUNICATIONS (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Looking into Living Cell Systems: Planar Waveguide Microfluidic NMR Detector for in Vitro Metabolomics of Tumor Spheroids
Ayten Kalfe et al.
ANALYTICAL CHEMISTRY (2015)
Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
Lucas B. Sullivan et al.
CELL (2015)
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Elena Enzo et al.
EMBO JOURNAL (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
Analytical methods in untargeted metabolomics: state of the art in 2015
Arnald Alonso et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2015)
The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation
Annie M. Tremblay et al.
CANCER CELL (2014)
Modeling Alveolar Soft Part Sarcomagenesis in the Mouse: A Role for Lactate in the Tumor Microenvironment
Matthew L. Goodwin et al.
CANCER CELL (2014)
Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors
Sameer H. Issaq et al.
CELL CYCLE (2014)
The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification
Christopher D. M. Fletcher
HISTOPATHOLOGY (2014)
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Bo Li et al.
NATURE (2014)
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
Jack F. Shern et al.
CANCER DISCOVERY (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
Xiang Chen et al.
CANCER CELL (2013)
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
David H. Munn et al.
TRENDS IN IMMUNOLOGY (2013)
Hypoxia-Dependent Modification of Collagen Networks Promotes Sarcoma Metastasis
T. S. Karin Eisinger-Mathason et al.
CANCER DISCOVERY (2013)
Serine, glycine and one-carbon units: cancer metabolism in full circle
Jason W. Locasale
NATURE REVIEWS CANCER (2013)
Consistency Test of the Cell Cycle: Roles for p53 and EGR1
Yaara Zwang et al.
CANCER RESEARCH (2012)
Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma
Andrew D. Kelly et al.
PLOS ONE (2011)
Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas
Barry S. Taylor et al.
CANCER DISCOVERY (2011)
Otto Warburg's contributions to current concepts of cancer metabolism
Willem H. Koppenol et al.
NATURE REVIEWS CANCER (2011)
Ketones and lactate fuel tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli et al.
CELL CYCLE (2010)
Integrated Proteomics and Genomics Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of Slug
Jilong Yang et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Utilization of positron emission tomography in the management of patients with sarcoma
Matthias R. Benz et al.
CURRENT OPINION IN ONCOLOGY (2009)
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Abdullah Yalcin et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Metabolic phenotyping in health and disease
Elaine Holmes et al.
CELL (2008)
Metabolomics: Current technologies and future trends
Katherine Hollywood et al.
PROTEOMICS (2006)
Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy:: Initial results
CK Wang et al.
RADIOLOGY (2004)